Barring major advances in prevention, diagnosis, and treatment of chronic obstructive pulmonary disease (COPD), hospitalizations for the disease will increase by more than 150% over the next 15 years in developed countries
Barring major advances in prevention, diagnosis, and treatment of chronic obstructive pulmonary disease (COPD)—and even taking into account steadily declining smoking rates—hospitalizations for the disease will increase by more than 150% over the next 15 years in developed countries, a Canadian study predicts.
Amir Khakban, MSc, of the University of British Columbia, Vancouver, Canada, and colleagues predict the greatest growth in numbers of COPD patients will occur in the older age group (75 years and up), in whom the absolute number will increase by 220%. The burden of inpatient care, measured as total annual inpatient days, will grow by 185%, they forecast. The new study was published in the American Journal of Respiratory Critical Care Medicine.
The data-driven forecasting analysis combines forecasts of population growth and aging among the 4.7 million residents of British Columbia, Canada, with health data to make the forecast about COPD incidence, prevalence, deaths, and total length of inpatient stays in hospitals. Data were from the province’s health databases from 2001 to 2010. The researchers predict that COPD hospitalizations are projected to more than double by 2030 in British Columbia. The increase is especially striking for hospital-based care, which already is responsible for the greatest share of the direct cost of COPD, they note. The predicted trend in inpatient care is likely to significantly impact healthcare systems, the authors conclude.
There are 2 competing factors regarding COPD, said coauthor Don D. Sin, MD, MPH. While there is a decrease in smoking, which should drive down the rate of COPD, counterbalancing that is the aging of the population, which is driving rates up because COPD is a disease of aging.
The study also found that:
The researchers said their study was designed to illustrate the pending epidemic of COPD hospitalizations in North America and most other industrialized nations, where there is already a high prevalence of COPD and where the population is aging. They said that the province of British Columbia was a good locale to use to predict future trends in COPD hospitalizations because all hospitalizations and healthcare resource utilizations occur within a publicly funded healthcare system and are accurately captured in provincial administrative databases.
Unless something is done soon to modify COPD disease burden, the authors conclude, our hospitals are shortly going to be overwhelmed with COPD patients. They recommend more aggressive strategies to identify the disease early, before patients must be hospitalized. Currently, 40%-50% of COPD patients are not diagnosed until they are hospitalized.
“We can do much better than that,” Sin told MedPage Today. “We need to treat patients early with the right medications and the right supportive care to keep them out of hospitals.”
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
ICS Use Tied to Fewer Exacerbations in Patients With Bronchiectasis and Elevated Blood Eosinophils
June 6th 2025Inhaled corticosteroid (ICS) use was common among patients with bronchiectasis and was associated with reduced exacerbations and hospitalizations in those with elevated blood eosinophil counts.
Read More
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More